Skip to content

Ketamine-assisted group psychotherapy integrating cognitive processing therapy to address identity-based trauma: a pilot study

Jae Sevelius, Rachel Lynn Golden, B. Stott, Natavi Orion Kozicz, Ronica Mukerjee, Sabrina R. Cluesman, Tennessee Jones, Talea Cornelius

Frontiers in Psychiatry January 22, 2026 DOI: 10.3389/fpsyt.2025.1727487 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Mixed-methods pilot study Qualitative Peer reviewed
Sample size 8
Population Transgender and gender-expansive adults
Interventions Ketamine-assisted psychotherapy Cognitive processing therapy
Duration Nine-week group intervention
Topics Esketamine Ketamine Psychedelic-assisted therapy
Keywords Cognition Intervention counseling Group psychotherapy Cognitive processing therapy Mental health Cognitive therapy Psychotherapist Clinical psychology Cognitive behavioral therapy Integrative psychotherapy Social cognitive theory
Citations 1
Key points The Kindred group-based ketamine-assisted psychotherapy program was feasible, highly acceptable, and associated with significant reductions in depression, anxiety, and cognitive fusion among transgender and gender-expansive adults.

Abstract

Introduction: Transgender and gender-expansive people experience high rates of depression, anxiety, and trauma-related distress, yet few evidence-based interventions are tailored to their needs. Kindred is a novel, group-based ketamine-assisted psychotherapy (KAP) program that integrates cognitive processing therapy (CPT) to address identity-based trauma.

Methods: This mixed-methods pilot study evaluated the feasibility, acceptability, and preliminary effects of Kindred among eight transgender and gender-expansive adults. The nine-week group KAP intervention alternated ketamine dosing sessions with CPT-based cognitive skills-building and integration sessions in a community-based clinical setting. Quantitative measures assessed changes in mood, cognitive fusion, substance use, suicidality, trauma symptoms, and gender-related well-being from pre- to post-intervention, while qualitative interviews explored participants’ experiences and perceived mechanisms of change.

Results: The intervention was feasible and highly acceptable, with 100% retention and high satisfaction ratings. Participants reported significant reductions in depression, anxiety, and cognitive fusion scores, alongside qualitative reports of decreased shame, suicidality, and internalized transphobia. Participants reported that group belonging, peer validation, and shared identity were important therapeutic factors that enhanced the impact of ketamine and CPT.

Discussion: Findings suggest that Kindred is a feasible and promising intervention for addressing mental health symptoms of identity-based trauma among TGE adults. Integrating evidence-based psychotherapy, such as CPT, with KAP in a group setting may promote synergistic cognitive, emotional, and social mechanisms of healing while facilitating increased accessibility.

Comparable studies

Other non-randomized and open-label trials on ketamine, most cited first.

Study Year Design Participants
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Intravenous arketamine for treatment-resistant depression: open-label pilot study Humans with treatment-resistant depression 2020 Open-label pilot trial n = 7
A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide. Hospitalized patients with Major Depressive Disorder and acute suicidal ideation and... 2024 Open label study n = 17
Ketamine Psychedelic Therapy (KPT): A Review of the Results of Ten Years of Research Alcoholic patients 1997 Controlled clinical trial n = 211
Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression Participants with DSM-IV-defined major depressive disorder and treatment-resistant... 2014 Pooled analysis of three clinical trials n = 97

Citations in the library

Explore topics